| Propofol group (n = 23) | Sevo group (n = 23) | P value |
---|---|---|---|
Intra-operative parameters | |||
 blood loss (ml. kg−1) | 10.4(9.3–13.3[5.2–29.0]) | 9.7(8.8–12.5[4.9–27.3]) | 0.804 |
 crystal fluid infused (ml.kg−1) | 31.1(25.2–32.6[17.8–41.5]) | 29.2(23.7–30.6[16.7–39.0]) | 0.972 |
 colloid fluid infused (ml. kg−1) | 22.2(14.8–29.6[14.8–37.0]) | 20.9(13.9–27.9[13.9–34.8]) | 0.155 |
 Cell-saver RBC infused (ml) | 250(250–500[0–1000]) | 250(250–500[0–1200]) | 0.848 |
 Receiving FFP (case) | 6(26.1%) | 8(34.8%) | 0.522 |
 Receiving allogeneic RBC (case) | 4(17.4%) | 5(21.7%) | 0.710 |
 urine volume (ml) | 800(500–1200[350–2000]) | 700(600–800[300–1400]) | 0.094 |
Postoperative parameters | |||
 POD1 | |||
  crystal fluid infused (ml. kg−1) | 29.2(26.2–29.6[23.6–37.0]) | 27.4(24.7–27.9[22.1–34.8]) | 0.878 |
  colloid fluid infused (ml. kg−1) | 14.4(8.9–16.3[8.9–29.6]) | 13.5(8.4–15.3[8.4–27.9]) | 0.666 |
  urine volume (ml) | 3445(2830–4000[1020–5530]) | 3330(2910–3920[2000–4460]) | 0.764 |
  chest tube drainage (ml) | 230(200–300[100–730]) | 330(210–530[130–740]) | 0.074 |
 POD2 | |||
  crystal fluid infused (ml. kg−1) | 27.1(26.2–29.4[16.8–40.0]) | 25.5(24.6–27.6[15.8–37.6]) | 0.860 |
  colloid fluid infused (ml. kg−1) | 8.9(8.9–12.9[3.0–23.7]) | 8.4(8.4–12.2[2.8–22.3]) | 0.372 |
  urine volume (ml) | 3420(2860–3990[1850–4730]) | 3460(2970–3780[1440–4940]) | 0.802 |
  chest tube drainage (ml) | 170(50–225[5–390]) | 150(90–240[20–490]) | 0.558 |